Thanks Trding for the info and sources.

I think NPs answer to misiu's CC question notes of .4ml being wasted from each 1.4ml vial.....at least that was my understanding. This doesn't impact the cost basis, but the number of patients we can treat with our expected $97M commercial inventory. I wonder if this wasted product due to safety data is the reason for Samsung producing clincial grade product and no commercial grade until early 2021?

Quote:

---

42:31 that's correct
42:33 so 1.4 million later the patient will
42:36 take out one milliliter point four would
42:39 be wasted because of the safety for the
42:42 first batches that we have this will be
42:44 resolved when we have previous range but
42:47 one point for your correct one
42:48 milliliter of that is a hundred and
42:50 seventy five milligrams outside

---

https://investorshangout.com/post/view?id=5553544